possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)

June 1999

The FDA is warning about a possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept).

There are 30 reports of serious infections...including 6 deaths.

Enbrel works by binding tumor necrosis factor (TNF)...a protein that leads to joint pain and inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

new med for type 2 diabetes, Avandia (rosiglitazone)
Neurology & Pain withdrawal symptoms after stopping an antidepressant
Neurology & Pain whether Aricept (donepezil) or vitamin E can PREVENT or delay Alzheimer's
Vioxx (rofecoxib), a new COX-2 inhibitor
possible interaction between Celebrex and warfarin
possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)
MSM, a new supplement that's being widely promoted for pain and arthritis
Dermatology Nizoral A-D, the first OTC ketoconazole shampoo for dandruff
Pediatrics prescribe Amoxil BID for children
Pediatrics large increase in clonidine poisonings in children
Pediatrics new conjugated pneumococcal vaccine that's being tested for INFANTS
Cardiology more aggressive treatment of dyslipidemia to prevent heart disease in WOMEN
Cardiology two new margarines that actually help LOWER cholesterol
DRUG therapy to help patients reduce or stop drinking
Women's Health Vivelle-Dot, a tiny new estrogen patch
Women's Health single-dose fluconazole during early pregnancy isn't likely to cause birth defects
Infectious Diseases Hepatitis C Check, the first home test kit for hepatitis C
Infectious Diseases some HIV patients can STOP taking drugs to prevent two opportunistic infections
Pharmacogenetics hear a lot about pharmacogenetics